JP2025507929A5 - - Google Patents
Info
- Publication number
- JP2025507929A5 JP2025507929A5 JP2024552283A JP2024552283A JP2025507929A5 JP 2025507929 A5 JP2025507929 A5 JP 2025507929A5 JP 2024552283 A JP2024552283 A JP 2024552283A JP 2024552283 A JP2024552283 A JP 2024552283A JP 2025507929 A5 JP2025507929 A5 JP 2025507929A5
- Authority
- JP
- Japan
- Prior art keywords
- fusion protein
- seq
- pharmaceutical composition
- proinsulin
- identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315296P | 2022-03-01 | 2022-03-01 | |
| US63/315,296 | 2022-03-01 | ||
| PCT/US2023/063510 WO2023168288A2 (en) | 2022-03-01 | 2023-03-01 | Insulin fusion protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507929A JP2025507929A (ja) | 2025-03-21 |
| JP2025507929A5 true JP2025507929A5 (https=) | 2026-03-10 |
Family
ID=87884362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552283A Pending JP2025507929A (ja) | 2022-03-01 | 2023-03-01 | インスリン融合タンパク質 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250188144A1 (https=) |
| EP (1) | EP4486796A4 (https=) |
| JP (1) | JP2025507929A (https=) |
| KR (1) | KR20240167718A (https=) |
| CN (1) | CN119562965A (https=) |
| AU (1) | AU2023228668A1 (https=) |
| CA (1) | CA3245376A1 (https=) |
| CL (1) | CL2024002605A1 (https=) |
| IL (1) | IL315354A (https=) |
| MX (1) | MX2024010693A (https=) |
| WO (1) | WO2023168288A2 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120173090B (zh) * | 2025-05-21 | 2025-07-29 | 华中农业大学 | 猫血清白蛋白突变体、及其cho细胞表达方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002364586A1 (en) * | 2001-12-21 | 2003-07-30 | Delta Biotechnology Limited | Albumin fusion proteins |
| US9505823B2 (en) * | 2006-08-07 | 2016-11-29 | TEV A Biopharmaceuticals USA, Inc. | Albumin-insulin fusion proteins |
| CA2676932C (en) * | 2007-02-01 | 2015-11-24 | Technion Research & Development Foundation Ltd. | Albumin fibers and fabrics and methods of generating and using same |
| TWI394580B (zh) * | 2008-04-28 | 2013-05-01 | Halozyme Inc | 超快起作用胰島素組成物 |
| BR112014015156A2 (pt) * | 2011-12-20 | 2020-10-27 | Indiana University Research And Technology Corporation | análogos de insulina à base de ctp, seus métodos de produção e uso no tratamento de hiperglicemia, bem como sequência de ácido nucleico e célula hospedeira |
| WO2022098906A1 (en) * | 2020-11-04 | 2022-05-12 | The Trustees Of The University Of Pennsylvania | Viral vectors encoding canine insulin for treatment of metabolic diseases in dogs |
| AU2023228669A1 (en) * | 2022-03-01 | 2024-09-19 | Scout Bio, Inc. | Viral vector genome encoding an insulin fusion protein |
-
2023
- 2023-03-01 KR KR1020247029510A patent/KR20240167718A/ko active Pending
- 2023-03-01 AU AU2023228668A patent/AU2023228668A1/en active Pending
- 2023-03-01 IL IL315354A patent/IL315354A/en unknown
- 2023-03-01 WO PCT/US2023/063510 patent/WO2023168288A2/en not_active Ceased
- 2023-03-01 JP JP2024552283A patent/JP2025507929A/ja active Pending
- 2023-03-01 US US18/843,112 patent/US20250188144A1/en active Pending
- 2023-03-01 CN CN202380034373.8A patent/CN119562965A/zh active Pending
- 2023-03-01 EP EP23764094.1A patent/EP4486796A4/en active Pending
- 2023-03-01 CA CA3245376A patent/CA3245376A1/en active Pending
-
2024
- 2024-08-30 MX MX2024010693A patent/MX2024010693A/es unknown
- 2024-08-30 CL CL2024002605A patent/CL2024002605A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020531002A5 (https=) | ||
| US20190248858A1 (en) | Novel feline erythropoietin receptor agonists | |
| JP6412183B2 (ja) | 作用持続時間が増した改変ポリペプチド | |
| US11845782B2 (en) | Relaxin fusion polypeptides and uses thereof | |
| AU762047B2 (en) | Insulin-like growth factor (IGF) I mutant variants | |
| JP6829928B2 (ja) | 二相性単鎖インスリン類似体 | |
| KR20110021758A (ko) | 이형체-특이적 인슐린 유사체 | |
| JP2011501959A5 (https=) | ||
| JP2013520175A (ja) | 可溶形および結晶形の長時間作用型インスリン類似体製剤 | |
| JP2012529297A5 (https=) | ||
| KR20150014962A (ko) | 장기 작용 폴리펩티드 및 그의 생산 및 투여 방법 | |
| WO2014165093A2 (en) | Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto | |
| JP2012505151A5 (https=) | ||
| IL114859A (en) | Glycoproteins, pharmaceutical and veterinary compositions containing the same and methods for the production thereof | |
| JP2025507929A5 (https=) | ||
| EP0725795B1 (en) | Single-chain forms of the glycoprotein hormone quartet | |
| EP3131925A1 (en) | Modified relaxin b chain peptides | |
| US20080293638A1 (en) | Albumin-fused ciliary neurotrophic factor | |
| JP2025509433A (ja) | ヒトインスリン類似体、その融合タンパク質及び医薬的使用 | |
| JP2025508981A5 (https=) | ||
| US11649275B2 (en) | Dual agonist fusion proteins | |
| JP2010213707A (ja) | アルブミン融合繊毛様神経栄養因子 | |
| JP2005506342A (ja) | インスリン耐性状態の治療及び診断 | |
| RU2024125882A (ru) | Слитый белок инсулина | |
| AU2016271292B2 (en) | An engineered CCL20 locked dimer polypeptide |